FDA Innovation And Integrity Will Be Goodman's Role Under Reorganization

FDA's Office of Chief Scientist will lose some specific responsibilities but gain a broader mission under a reorganization proposed by Commissioner Margaret Hamburg

More from Archive

More from Pink Sheet